These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8780023)

  • 1. Blockade of FG 7142-induced increased dopamine utilization by the glycine/NMDA receptor antagonist (+)-HA 966.
    Horger BA; Elsworth JD; Roth RH
    J Neurochem; 1996 May; 66(5):1959-62. PubMed ID: 8780023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142.
    Horger BA; Elsworth JD; Roth RH
    J Neurochem; 1995 Aug; 65(2):770-4. PubMed ID: 7616234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist.
    Morrow BA; Clark WA; Roth RH
    Eur J Pharmacol; 1993 Jul; 238(2-3):255-62. PubMed ID: 8405096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
    Goldstein LE; Rasmusson AM; Bunney BS; Roth RH
    J Neurosci; 1994 Aug; 14(8):4937-50. PubMed ID: 8046462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-701,324, a glycine/NMDA receptor antagonist, blocks the increase of cortical dopamine metabolism by stress and DMCM.
    Hutson PH; Barton CL
    Eur J Pharmacol; 1997 May; 326(2-3):127-32. PubMed ID: 9196264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress.
    King D; Finlay JM
    Brain Res; 1997 Sep; 767(2):192-200. PubMed ID: 9367247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
    Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
    Hutson PH; Bristow LJ; Thorn L; Tricklebank MD
    Br J Pharmacol; 1991 Aug; 103(4):2037-44. PubMed ID: 1655150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors.
    Feenstra MG; Botterblom MH; van Uum JF
    J Neurochem; 1998 Mar; 70(3):1104-13. PubMed ID: 9489731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat.
    Bassareo V; Tanda G; Petromilli P; Giua C; Di Chiara G
    Psychopharmacology (Berl); 1996 Apr; 124(4):293-9. PubMed ID: 8739543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitization.
    Morrow BA; Lee EJ; Taylor JR; Elsworth JD; Nye HE; Roth RH
    J Pharmacol Exp Ther; 1997 Nov; 283(2):712-21. PubMed ID: 9353390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens.
    Serrano A; D'Angio M; Scatton B
    Eur J Pharmacol; 1989 Mar; 162(1):157-66. PubMed ID: 2566493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
    Del Arco A; Mora F; Mohammed AH; Fuxe K
    J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A; Takahashi K; Nishikawa T
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area.
    Cornish JL; Nakamura M; Kalivas PW
    J Pharmacol Exp Ther; 2001 Jul; 298(1):226-33. PubMed ID: 11408546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area.
    Schilström B; De Villiers S; Malmerfelt A; Svensson TH; Nomikos GG
    Synapse; 2000 Jun; 36(4):314-21. PubMed ID: 10819909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors.
    Atack JR; Hutson PH; Collinson N; Marshall G; Bentley G; Moyes C; Cook SM; Collins I; Wafford K; McKernan RM; Dawson GR
    Br J Pharmacol; 2005 Feb; 144(3):357-66. PubMed ID: 15655523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis.
    Bradberry CW; Lory JD; Roth RH
    J Neurochem; 1991 Mar; 56(3):748-52. PubMed ID: 1993892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.